Which term refers to an independent data-monitoring committee that may be established by the sponsor to assess at intervals the progress of a clinical trial, the safety data, and the critical efficacy endpoints, and to recommend to the sponsor whether to continue, modify, or stop a trial?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which term refers to an independent data-monitoring committee that may be established by the sponsor to assess at intervals the progress of a clinical trial, the safety data, and the critical efficacy endpoints, and to recommend to the sponsor whether to continue, modify, or stop a trial?

Explanation:
The main idea is independent oversight of trial data. An Independent Data-Monitoring Committee (IDMC) is a body that operates independently from the sponsor and investigators to periodically review accumulating trial data—focusing on safety data, trial progress, and critical efficacy endpoints. Based on this ongoing review, the IDMC makes recommendations to the sponsor about whether to continue, modify, or stop the trial. This independence helps prevent bias in safety decisions and in decisions about continuing the study. Other terms described in the options don’t fit this function. An inspection is a regulatory check of trial conduct, not a standing monitoring body. Documentation refers to the trial records themselves. Direct access concerns who can view or access the data, not a separate committee charged with ongoing data review. The term that best fits the described role is Independent Data-Monitoring Committee.

The main idea is independent oversight of trial data. An Independent Data-Monitoring Committee (IDMC) is a body that operates independently from the sponsor and investigators to periodically review accumulating trial data—focusing on safety data, trial progress, and critical efficacy endpoints. Based on this ongoing review, the IDMC makes recommendations to the sponsor about whether to continue, modify, or stop the trial. This independence helps prevent bias in safety decisions and in decisions about continuing the study.

Other terms described in the options don’t fit this function. An inspection is a regulatory check of trial conduct, not a standing monitoring body. Documentation refers to the trial records themselves. Direct access concerns who can view or access the data, not a separate committee charged with ongoing data review. The term that best fits the described role is Independent Data-Monitoring Committee.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy